BioMarin Pharmaceutical announced that the company has entered into a preclinical collaboration and license agreement with DiNAQOR, a gene therapy platform company,
BioMarin Pharmaceutical announced that the company has entered into a preclinical collaboration and license agreement with DiNAQOR, a gene therapy platform company,